Therapeutically, small-molecule drugs targeting TLR4 inhibitors such as TAK-242, GX-50, baicalein, etc. can significantly reduce neuroinflammation and neuronal damage by interfering with the TLR4 signaling pathway, thereby improving cognitive function in AD mouse models (23). Here, TLR4 is linked to Alzheimer disease.